France to Reimburse Patients for Anti-Obesity Drugs
The move, which will be effective from the middle of next month, makes Paris the first government in the EU to subsidize such medications.
France to Reimburse Patients for Anti-Obesity Drugs France will begin reimbursing severely obese individuals for weight-loss drugs starting in mid-June. The French Health Minister announced that Paris will subsidize medications like Wegovy and Mounjaro. This initiative makes France the first country in the European Union to offer permanent reimbursement for these drugs.
- France will start reimbursing severely obese patients for weight-loss drugs in mid-June.
- Paris will subsidize drugs from Novo Nordisk (Wegovy) and Eli Lilly (Mounjaro).
- France is the first EU country to provide permanent reimbursement for these medications.
- The reimbursement will cover 65 percent of the cost, with full coverage for patients with comorbidities like high blood pressure or diabetes.
Write a comment